Conversely, primary fibroblasts from PD patients display upregulation of PGC-1α, even if its target genes involved in mitochondrial biogenesis and fatty acid β-oxidation processes are unchanged or downregulated and mitochondria display significant morphometric changes [158,159]. The gene discussed is PPARGC1A; the disease is Parkinson disease.